BSE Live
Oct 27, 14:23Prev. Close
494.05
Open Price
491.00
Bid Price (Qty.)
491.05 (40)
Offer Price (Qty.)
491.70 (1)
NSE Live
Oct 27, 14:23Prev. Close
493.95
Open Price
493.95
Bid Price (Qty.)
491.20 (14)
Offer Price (Qty.)
491.55 (9)
| Cash Flow of Aarti Drugs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 198.75 | 192.48 | 204.81 | 255.50 | 337.71 | |
| Net CashFlow From Operating Activities | 220.08 | 337.10 | 162.28 | 39.90 | 154.08 | |
| Net Cash Used In Investing Activities | -134.92 | -187.09 | -131.14 | -125.36 | -68.93 | |
| Net Cash Used From Financing Activities | -84.60 | -148.81 | -30.54 | 84.11 | -85.28 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.56 | 1.20 | 0.61 | -1.35 | -0.13 | |
| Cash And Cash Equivalents Begin of Year | 2.72 | 1.52 | 1.49 | 2.84 | 2.98 | |
| Cash And Cash Equivalents End Of Year | 3.28 | 2.72 | 2.10 | 1.49 | 2.84 |
21.07.2025
18.07.2025
Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y
18.07.2025
Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y
07.05.2025